118 related articles for article (PubMed ID: 15013748)
21. MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes.
Harmon AW; Paul DS; Patel YM
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E758-66. PubMed ID: 15172888
[TBL] [Abstract][Full Text] [Related]
22. Ascorbic acid 6-palmitate suppresses gap-junctional intercellular communication through phosphorylation of connexin 43 via activation of the MEK-ERK pathway.
Lee KM; Kwon JY; Lee KW; Lee HJ
Mutat Res; 2009 Jan; 660(1-2):51-6. PubMed ID: 19026667
[TBL] [Abstract][Full Text] [Related]
23. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
24. Nuclear functions of the influenza A and B viruses NS1 proteins: do they play a role in viral mRNA export?
Schneider J; Wolff T
Vaccine; 2009 Oct; 27(45):6312-6. PubMed ID: 19840666
[TBL] [Abstract][Full Text] [Related]
25. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
26. Coordinating ERK/MAPK signalling through scaffolds and inhibitors.
Kolch W
Nat Rev Mol Cell Biol; 2005 Nov; 6(11):827-37. PubMed ID: 16227978
[TBL] [Abstract][Full Text] [Related]
27. Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts.
Ferrer-Alcón M; García-Fuster MJ; La Harpe R; García-Sevilla JA
J Neurochem; 2004 Jul; 90(1):220-30. PubMed ID: 15198681
[TBL] [Abstract][Full Text] [Related]
28. Role of the p21-activated kinases (PAKs) in influenza A virus replication.
Pascua PN; Lee JH; Song MS; Park SJ; Baek YH; Ann BH; Shin EY; Kim EG; Choi YK
Biochem Biophys Res Commun; 2011 Oct; 414(3):569-74. PubMed ID: 21982772
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
Wan PT; Garnett MJ; Roe SM; Lee S; Niculescu-Duvaz D; Good VM; Jones CM; Marshall CJ; Springer CJ; Barford D; Marais R;
Cell; 2004 Mar; 116(6):855-67. PubMed ID: 15035987
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export.
Wu MS; Yen HR; Chang CW; Peng TY; Hsieh CF; Chen CJ; Lin TY; Horng JT
J Ethnopharmacol; 2011 Apr; 134(3):614-23. PubMed ID: 21232589
[TBL] [Abstract][Full Text] [Related]
31. Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model.
Laure M; Hamza H; Koch-Heier J; Quernheim M; Müller C; Schreiber A; Müller G; Pleschka S; Ludwig S; Planz O
Antiviral Res; 2020 Jun; 178():104806. PubMed ID: 32304723
[TBL] [Abstract][Full Text] [Related]
32. The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression.
Schräder T; Dudek SE; Schreiber A; Ehrhardt C; Planz O; Ludwig S
Antiviral Res; 2018 Sep; 157():80-92. PubMed ID: 29990517
[TBL] [Abstract][Full Text] [Related]
33. Late activation of the Raf/MEK/ERK pathway is required for translocation of the respiratory syncytial virus F protein to the plasma membrane and efficient viral replication.
Preugschas HF; Hrincius ER; Mewis C; Tran GVQ; Ludwig S; Ehrhardt C
Cell Microbiol; 2019 Jan; 21(1):e12955. PubMed ID: 30223301
[TBL] [Abstract][Full Text] [Related]
34. Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors.
Wityak J; Hobbs FW; Gardner DS; Santella JB; Petraitis JJ; Sun JH; Favata MF; Daulerio AJ; Horiuchi KY; Copeland RA; Scherle PA; Jaffe BD; Trzaskos JM; Magolda RL; Trainor GL; Duncia JV
Bioorg Med Chem Lett; 2004 Mar; 14(6):1483-6. PubMed ID: 15006386
[TBL] [Abstract][Full Text] [Related]
35. Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling Pathways.
Holzberg M; Boergeling Y; Schräder T; Ludwig S; Ehrhardt C
Front Microbiol; 2017; 8():2426. PubMed ID: 29312159
[TBL] [Abstract][Full Text] [Related]
36. Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2.
Hoffmann H; Ebensperger M; Schönsiegel A; Hamza H; Koch-Heier J; Schreiber A; Ludwig S; Schindler M; Planz O
Front Cell Infect Microbiol; 2023; 13():1264983. PubMed ID: 37965261
[TBL] [Abstract][Full Text] [Related]
37. Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling.
Marjuki H; Alam MI; Ehrhardt C; Wagner R; Planz O; Klenk HD; Ludwig S; Pleschka S
J Biol Chem; 2006 Jun; 281(24):16707-15. PubMed ID: 16608852
[TBL] [Abstract][Full Text] [Related]
38. Raf/MEK/ERK pathway activation is required for Junín virus replication.
Rodríguez ME; Brunetti JE; Wachsman MB; Scolaro LA; Castilla V
J Gen Virol; 2014 Apr; 95(Pt 4):799-805. PubMed ID: 24421112
[TBL] [Abstract][Full Text] [Related]
39. Replication of influenza B virus: biological functions of viral neuraminidase.
Maeno K
Nagoya J Med Sci; 1994 Mar; 57(1-4):1-17. PubMed ID: 7898558
[No Abstract] [Full Text] [Related]
40. MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases.
Ludwig S; Pleschka S; Planz O
Curr Opin Virol; 2023 Apr; 59():101304. PubMed ID: 36841033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
